USPTO Patent Grant: Self-Healing Wireless Sensor Network for Medical Systems

The USPTO has granted a patent (US12581367B2) to RTX A/S for a medical system featuring a self-healing wireless sensor network. This technology aims to improve the reliability and reduce latency in medical monitoring systems, such as CPAP devices.

USPTO Patent Grant: LLM Persona Agent Governance for Regulated Environments

The USPTO has granted a patent to OneSource Solutions International, Inc. for a system and method for decentralized governance of large language model (LLM) persona agents in regulated environments, such as healthcare. The patented technology aims to provide real-time governance, supervision, and audit capabilities for LLM agents operating within these sensitive sectors.

USPTO Patent US12581269B1: Motion Event Evaluation Using Machine Learning

The USPTO has granted patent US12581269B1 to NoCell Technologies, LLC for a method of evaluating motion event types using machine learning on network devices. The patent describes systems and methods for detecting and classifying motion events, potentially leading to policy implementation on devices.

USPTO Patent Grant: Data Security for Digital Therapeutics

The USPTO has granted a patent (US12580899B2) to Click Therapeutics, Inc. for a method ensuring data security in digital therapeutics. The patent covers systems and methods for encrypting, anonymizing, and transmitting patient-generated event data between patient devices and healthcare provider systems.

USPTO Grants Urination Prediction Monitoring Patent

The USPTO has granted patent US12580085B2 to GOGO BAND, INC. for a system designed to predict and monitor urination events using wearable and mobile devices. The patent covers methods for collecting biometric and environmental data to determine predicted urination times and provide stimuli to users or caregivers.

USPTO Patent Grant: Plasma piRNA Combination for Gastric Cancer Diagnosis

The USPTO has granted patent US12580080B2 to The First Affiliated Hospital of Wenzou Medical University for a plasma piRNA combination for the early diagnosis of gastric cancer. The patent describes a diagnostic model that uses piRNA expression profiles to predict gastric cancer risk with high accuracy.

USPTO Patent Grant: Hexokinase 1b for Cancer Prognosis and Treatment

The USPTO has granted a patent (US12578339B2) for hexokinase 1 isoform B (HK1b) as a prognosis marker and treatment target for cancer. The patent was filed on July 19, 2020, and granted on March 17, 2026.

USPTO Patent Grant: Selective Metal Recovery Agent and Method

The USPTO has granted patent US12577633B2 to Galdieria Co., Ltd. for an agent and method for selective metal recovery using materials derived from algae or porphyrins. The patent details a process involving adding the agent to a metal solution and then recovering the metal.

USPTO Patent Grant: CRISPR-Cas13 for SARS-CoV-2 Detection

The USPTO has granted patent US12577625B2 to The J. David Gladstone Institutes for a method using CRISPR-Cas13 enzyme to detect and quantify SARS-CoV-2 RNA. This technology aims to provide rapid, field-deployable diagnostics for SARS-CoV-2 infection, including variant identification.

USPTO Grants Patent for Single Molecule Peptide Sequencing

The USPTO has granted a patent (US12578345B2) to The University of Texas System for methods of single molecule peptide sequencing. The patent covers techniques for identifying polypeptide sequences within a mixture by immobilizing, labeling, and analyzing the polypeptide.